| NCT02824198 |
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule |
https://ClinicalTrials.gov/show/NCT02824198 |
Completed |
Sanofi |
2017-03-18 |
| NCT04350905 |
Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-endemic Participants in Cambodia |
https://ClinicalTrials.gov/show/NCT04350905 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-02-28 |
| NCT02450838 |
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) |
https://ClinicalTrials.gov/show/NCT02450838 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-10-31 |
| NCT01782300 |
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart |
https://ClinicalTrials.gov/show/NCT01782300 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-03-31 |
| NCT02021968 |
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02021968 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-03-31 |
| NCT03341637 |
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s) |
https://ClinicalTrials.gov/show/NCT03341637 |
Completed |
Takeda |
2019-01-26 |
| NCT02993757 |
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® |
https://ClinicalTrials.gov/show/NCT02993757 |
Completed |
Sanofi |
2019-05-27 |
| NCT02992418 |
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02992418 |
Completed |
Sanofi |
2019-11-28 |
| NCT02979535 |
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® |
https://ClinicalTrials.gov/show/NCT02979535 |
Completed |
Sanofi |
2019-03-25 |
| NCT02879266 |
Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age |
https://ClinicalTrials.gov/show/NCT02879266 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-09-07 |
| NCT02873260 |
Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30 |
https://ClinicalTrials.gov/show/NCT02873260 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-11-30 |
| NCT02833584 |
Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults |
https://ClinicalTrials.gov/show/NCT02833584 |
Completed |
Phramongkutklao College of Medicine and Hospital |
2017-12-31 |
| NCT02747927 |
Efficacy, Safety and Immunogenicity of Takeda’s Tetravalent Dengue Vaccine (TDV) in Healthy Children |
https://ClinicalTrials.gov/show/NCT02747927 |
Active, not recruiting |
Takeda |
2018-07-11 |
| NCT02684383 |
Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine |
https://ClinicalTrials.gov/show/NCT02684383 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-07-31 |
| NCT02678455 |
Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh |
https://ClinicalTrials.gov/show/NCT02678455 |
Active, not recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-02-29 |
| NCT02628444 |
Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age |
https://ClinicalTrials.gov/show/NCT02628444 |
Active, not recruiting |
Sanofi |
2020-06-30 |
| NCT02623725 |
Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule |
https://ClinicalTrials.gov/show/NCT02623725 |
Completed |
Sanofi |
2016-11-23 |
| NCT02570152 |
A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia |
https://ClinicalTrials.gov/show/NCT02570152 |
Completed |
GlaxoSmithKline |
2019-06-28 |
| NCT04422782 |
New Tools for Predicting Capillary Leak Shock During Dengue Fever |
https://ClinicalTrials.gov/show/NCT04422782 |
Active, not recruiting |
Centre Hospitalier de Cayenne |
2022-05-14 |
| NCT02741128 |
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults |
https://ClinicalTrials.gov/show/NCT02741128 |
Active, not recruiting |
Sanofi |
2022-06-30 |
| NCT02433652 |
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2 |
https://ClinicalTrials.gov/show/NCT02433652 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-11-30 |
| NCT02421367 |
Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults |
https://ClinicalTrials.gov/show/NCT02421367 |
Completed |
U.S. Army Medical Research and Development Command |
2016-12-31 |
| NCT02406729 |
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine |
https://ClinicalTrials.gov/show/NCT02406729 |
Active, not recruiting |
Butantan Institute |
2021-08-31 |
| NCT02392325 |
Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02392325 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-07-31 |
| NCT02332733 |
Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand |
https://ClinicalTrials.gov/show/NCT02332733 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2018-10-26 |
| NCT02317900 |
Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT02317900 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-11-30 |
| NCT02302066 |
Safety and Immunogenicity of Different Schedules of Takeda’s Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants |
https://ClinicalTrials.gov/show/NCT02302066 |
Completed |
Takeda |
2019-02-18 |
| NCT02239614 |
TDENV PIV and LAV Dengue Prime-boost Strategy |
https://ClinicalTrials.gov/show/NCT02239614 |
Completed |
U.S. Army Medical Research and Development Command |
2016-02-17 |
| NCT02193087 |
Safety and Immunogenicity of Three Formulations of Takeda’s Tetravalent Dengue Vaccine Candidate (TDV) |
https://ClinicalTrials.gov/show/NCT02193087 |
Completed |
Takeda |
2015-05-19 |
| NCT01943825 |
Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine |
https://ClinicalTrials.gov/show/NCT01943825 |
Completed |
Sanofi |
2015-11-25 |
| NCT01931176 |
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT01931176 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-12-31 |
| NCT01843621 |
A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children |
https://ClinicalTrials.gov/show/NCT01843621 |
Completed |
U.S. Army Medical Research and Development Command |
2005-02-28 |
| NCT01728792 |
Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity |
https://ClinicalTrials.gov/show/NCT01728792 |
Completed |
Takeda |
2013-11-01 |
| NCT01702857 |
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) |
https://ClinicalTrials.gov/show/NCT01702857 |
Completed |
U.S. Army Medical Research and Development Command |
2017-01-20 |
| NCT01696422 |
Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine |
https://ClinicalTrials.gov/show/NCT01696422 |
Active, not recruiting |
Butantan Institute |
2016-04-30 |
| NCT01666652 |
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults |
https://ClinicalTrials.gov/show/NCT01666652 |
Completed |
U.S. Army Medical Research and Development Command |
2015-09-30 |
| NCT01619969 |
Celgosivir as a Treatment Against Dengue |
https://ClinicalTrials.gov/show/NCT01619969 |
Completed |
Singapore General Hospital |
2013-03-31 |
| NCT01601613 |
Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever |
https://ClinicalTrials.gov/show/NCT01601613 |
Completed |
Novo Nordisk A/S |
2002-11-30 |
| NCT01550289 |
Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India |
https://ClinicalTrials.gov/show/NCT01550289 |
Completed |
Sanofi |
2013-12-31 |
| NCT01542632 |
A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT01542632 |
Completed |
Takeda |
2014-01-01 |
| NCT01511250 |
Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years |
https://ClinicalTrials.gov/show/NCT01511250 |
Completed |
Takeda |
2016-04-01 |
| NCT01506570 |
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine |
https://ClinicalTrials.gov/show/NCT01506570 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-09-30 |
| NCT01502735 |
Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease |
https://ClinicalTrials.gov/show/NCT01502735 |
Completed |
U.S. Army Medical Research and Development Command |
2013-09-30 |
| NCT01502358 |
Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease |
https://ClinicalTrials.gov/show/NCT01502358 |
Completed |
U.S. Army Medical Research and Development Command |
2013-12-31 |
| NCT01488890 |
Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine |
https://ClinicalTrials.gov/show/NCT01488890 |
Completed |
Sanofi |
2013-09-27 |
| NCT01477580 |
Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001) |
https://ClinicalTrials.gov/show/NCT01477580 |
Completed |
Merck Sharp & Dohme Corp. |
2014-01-23 |
| NCT01443247 |
Role of Andi-d in Dengue Fever: a Pilot Study |
https://ClinicalTrials.gov/show/NCT01443247 |
Completed |
Postgraduate Institute of Medical Education and Research |
2011-09-30 |
| NCT01436396 |
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT01436396 |
Completed |
Sanofi |
2013-09-30 |
| NCT01411241 |
Study of a Booster Injection of Pentaximâ„¢ Vaccine Administered With Dengue Vaccine in Healthy Toddlers |
https://ClinicalTrials.gov/show/NCT01411241 |
Completed |
Sanofi |
2014-02-04 |
| NCT01391819 |
Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children |
https://ClinicalTrials.gov/show/NCT01391819 |
Completed |
GlaxoSmithKline |
2015-01-30 |
| NCT01374516 |
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America |
https://ClinicalTrials.gov/show/NCT01374516 |
Completed |
Sanofi |
2014-11-30 |
| NCT04133987 |
Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan |
https://ClinicalTrials.gov/show/NCT04133987 |
Recruiting |
National Taiwan University Hospital |
2020-04-30 |
| NCT04076254 |
Resuscitation With Albumin 5% in Dengue Haemorrhagic Fever |
https://ClinicalTrials.gov/show/NCT04076254 |
Recruiting |
Indonesia University |
2019-09-30 |
| NCT04063774 |
Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in Colombia |
https://ClinicalTrials.gov/show/NCT04063774 |
Completed |
Universidad del Valle, Colombia |
2018-07-15 |
| NCT04035278 |
A Phase 1 Safety Study of Dengusiil in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04035278 |
Recruiting |
Serum Institute of India Pvt. Ltd. |
2020-12-30 |
| NCT03999996 |
Long-Term Safety and Antibody Persistence of TDV and Impact of a Booster Dose |
https://ClinicalTrials.gov/show/NCT03999996 |
Active, not recruiting |
Takeda |
2022-03-07 |
| NCT03883620 |
Safety Study of Dengushield in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03883620 |
Completed |
Serum Institute of India Pvt. Ltd. |
2019-12-23 |
| NCT03869060 |
Expansion of a Dengue-1 Live Virus Human Challenge |
https://ClinicalTrials.gov/show/NCT03869060 |
Completed |
State University of New York - Upstate Medical University |
2019-09-20 |
| NCT03831503 |
A Study of INO-A002 in Healthy Dengue Virus-naive Adults |
https://ClinicalTrials.gov/show/NCT03831503 |
Active, not recruiting |
University of Pennsylvania |
2021-02-28 |
| NCT03799237 |
Combating Dengue With Innovative, Paradigm-shift-Strategies: Early Dengue Surveillance in Adult Aedes Mosquitoes |
https://ClinicalTrials.gov/show/NCT03799237 |
Recruiting |
University of Malaya |
2020-03-31 |
| NCT03771963 |
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults |
https://ClinicalTrials.gov/show/NCT03771963 |
Completed |
Takeda |
2019-10-19 |
| NCT03746015 |
Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults |
https://ClinicalTrials.gov/show/NCT03746015 |
Active, not recruiting |
Takeda |
2021-02-21 |
| NCT02372175 |
Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain |
https://ClinicalTrials.gov/show/NCT02372175 |
Completed |
U.S. Army Medical Research and Development Command |
2019-06-28 |
| NCT03485144 |
A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan |
https://ClinicalTrials.gov/show/NCT03485144 |
Completed |
Medigen Vaccine Biologics Corp. |
2019-05-10 |
| NCT03432442 |
Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients |
https://ClinicalTrials.gov/show/NCT03432442 |
Recruiting |
Mahidol University |
2019-07-31 |
| NCT03423173 |
Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue |
https://ClinicalTrials.gov/show/NCT03423173 |
Completed |
Takeda |
2018-07-20 |
| NCT01224639 |
Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever |
https://ClinicalTrials.gov/show/NCT01224639 |
Completed |
Takeda |
2011-06-09 |
| NCT03416036 |
Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge |
https://ClinicalTrials.gov/show/NCT03416036 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-01-17 |
| NCT01254422 |
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia |
https://ClinicalTrials.gov/show/NCT01254422 |
Completed |
Sanofi |
2012-09-28 |
| NCT01187433 |
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America |
https://ClinicalTrials.gov/show/NCT01187433 |
Completed |
Sanofi |
2012-10-31 |
| NCT01134263 |
Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia |
https://ClinicalTrials.gov/show/NCT01134263 |
Completed |
Sanofi |
2012-11-30 |
| NCT01096576 |
A Study of Balapiravir in Patients With Dengue Virus Infection |
https://ClinicalTrials.gov/show/NCT01096576 |
Completed |
Hoffmann-La Roche |
2011-04-30 |
| NCT01084291 |
Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine |
https://ClinicalTrials.gov/show/NCT01084291 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-05-31 |
| NCT01073306 |
Safety and Immune Response to an Investigational Dengue Type 2 Vaccine |
https://ClinicalTrials.gov/show/NCT01073306 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-06-30 |
| NCT01072786 |
Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine |
https://ClinicalTrials.gov/show/NCT01072786 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-06-30 |
| NCT01064141 |
A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines |
https://ClinicalTrials.gov/show/NCT01064141 |
Completed |
Sanofi |
2012-09-30 |
| NCT01110551 |
Tetravalent Chimeric Dengue Vaccine Trial |
https://ClinicalTrials.gov/show/NCT01110551 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-04-30 |
| NCT01030211 |
Adult Dengue Platelet Study |
https://ClinicalTrials.gov/show/NCT01030211 |
Completed |
Tan Tock Seng Hospital |
2014-12-31 |
| NCT00993447 |
Immunogenicity and Safety of Sanofi Pasteur’s CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America |
https://ClinicalTrials.gov/show/NCT00993447 |
Completed |
Sanofi |
2011-09-30 |
| NCT00920517 |
Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine |
https://ClinicalTrials.gov/show/NCT00920517 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-01-31 |
| NCT00919178 |
Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus |
https://ClinicalTrials.gov/show/NCT00919178 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-05-31 |
| NCT00883441 |
Implementation Research of New Dengue Vector Control Tools |
https://ClinicalTrials.gov/show/NCT00883441 |
Completed |
Institute of Tropical Medicine, Belgium |
2009-02-28 |
| NCT00880893 |
Study of Sanofi Pasteur’s CYD Dengue Vaccine in Healthy Subjects in Singapore |
https://ClinicalTrials.gov/show/NCT00880893 |
Completed |
Sanofi |
2014-10-31 |
| NCT00875524 |
Study of ChimeriVaxâ„¢ Tetravalent Dengue Vaccine in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00875524 |
Completed |
Sanofi |
2014-08-31 |
| NCT03612609 |
Pilot Study to Detect DENGUE Virus in Sperm |
https://ClinicalTrials.gov/show/NCT03612609 |
Completed |
University Hospital, Toulouse |
2019-08-07 |
| NCT03525119 |
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine |
https://ClinicalTrials.gov/show/NCT03525119 |
Completed |
Takeda |
2018-12-28 |
| NCT00936429 |
Study of HBV-001 D1 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00936429 |
Completed |
Hawaii Biotech, Inc. |
2010-07-31 |
| NCT02887482 |
Study of GLS-5700 in Dengue Virus Seropositive Adults |
https://ClinicalTrials.gov/show/NCT02887482 |
Completed |
GeneOne Life Science, Inc. |
2017-10-31 |
| NCT00842530 |
Efficacy and Safety of Dengue Vaccine in Healthy Children |
https://ClinicalTrials.gov/show/NCT00842530 |
Completed |
Sanofi |
2013-09-30 |
| NCT01436422 |
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine |
https://ClinicalTrials.gov/show/NCT01436422 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-03-31 |
| NCT03342898 |
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT03342898 |
Completed |
Takeda |
2018-05-29 |
| NCT03141138 |
Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine |
https://ClinicalTrials.gov/show/NCT03141138 |
Active, not recruiting |
U.S. Army Medical Research and Development Command |
2020-06-30 |
| NCT02425098 |
Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda’s Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore |
https://ClinicalTrials.gov/show/NCT02425098 |
Completed |
Takeda |
2017-09-18 |
| NCT01373281 |
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia |
https://ClinicalTrials.gov/show/NCT01373281 |
Completed |
Sanofi |
2014-08-01 |
| NCT00788151 |
Study of ChimeriVaxâ„¢ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years |
https://ClinicalTrials.gov/show/NCT00788151 |
Completed |
Sanofi |
2010-02-16 |
| NCT00740155 |
Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults |
https://ClinicalTrials.gov/show/NCT00740155 |
Completed |
Sanofi |
2009-10-31 |
| NCT00730288 |
Study of ChimeriVaxâ„¢ Dengue Tetravalent Vaccine in Adult Subjects |
https://ClinicalTrials.gov/show/NCT00730288 |
Completed |
Sanofi |
2007-08-31 |
| NCT00712803 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3’Ddelta30) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00712803 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-09-30 |
| NCT00617344 |
Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US |
https://ClinicalTrials.gov/show/NCT00617344 |
Completed |
Sanofi |
2009-12-31 |
| NCT00473135 |
Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine |
https://ClinicalTrials.gov/show/NCT00473135 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2010-01-31 |
| NCT00458120 |
Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus |
https://ClinicalTrials.gov/show/NCT00458120 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-08-31 |
| NCT00468858 |
A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children |
https://ClinicalTrials.gov/show/NCT00468858 |
Completed |
U.S. Army Medical Research and Development Command |
2010-04-30 |
| NCT00384670 |
A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children |
https://ClinicalTrials.gov/show/NCT00384670 |
Completed |
U.S. Army Medical Research and Development Command |
2004-05-31 |
| NCT00375726 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00375726 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-09-30 |
| NCT00370682 |
A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand |
https://ClinicalTrials.gov/show/NCT00370682 |
Completed |
U.S. Army Medical Research and Development Command |
2008-02-29 |
| NCT00350337 |
A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults |
https://ClinicalTrials.gov/show/NCT00350337 |
Completed |
U.S. Army Medical Research and Development Command |
2007-06-30 |
| NCT00322946 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00322946 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-08-31 |
| NCT00322049 |
A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants |
https://ClinicalTrials.gov/show/NCT00322049 |
Completed |
U.S. Army Medical Research and Development Command |
2009-06-30 |
| NCT00290147 |
Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine |
https://ClinicalTrials.gov/show/NCT00290147 |
Completed |
U.S. Army Medical Research and Development Command |
2006-12-31 |
| NCT00270699 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00270699 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-12-31 |
| NCT00239577 |
A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults |
https://ClinicalTrials.gov/show/NCT00239577 |
Completed |
GlaxoSmithKline |
2007-06-19 |
| NCT00094705 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00094705 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-04-30 |
| NCT00089908 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00089908 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-11-30 |
| NCT00831012 |
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31â€7164) in Healthy Adults |
https://ClinicalTrials.gov/show/NCT00831012 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2011-06-30 |